{"disease":{"id":"belimumab","name":"belimumab"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07053137","title":"A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Yipeng Liu","has_results":false},{"nct_id":"NCT05588830","title":"The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort Study","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT07031674","title":"Comparing Efficacy and Safety of Telitacicept and Belimumab in Lupus Nephritis: A Retrospective Multicenter Cohort Study.","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Yipeng Liu","has_results":false},{"nct_id":"NCT05585671","title":"Belimumab In Prevention of LN","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"RenJi Hospital","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}